Do you want to read an article? Please log in or register.
Prognostic significance of lymphovascular space invasion extent across molecular classes in early-stage endometrial cancer: A large retrospective analysis
Gynecologic Cancer
Related content
Gynecologic Cancer
Surgical stage in the era of molecular profiling of endometrial cancer
Eur J Cancer
Kasius JC, Kildal W, Vrede SW, Askautrud HA, Pradhan M, van Altena AM, Tobin KR, Knoll K, Reijnen C, Reimann S, Dackus G, Vlatkovic L, Huvila J, Steinlechner M, Tubita V, Gil-Moreno A, Snijders MPLM, Vos MC, Hveem TS, Asberger J, Zeimet AG, Matias-Guiu X, Lindemann K, Weinberger V, Visser NCM, Kristensen GB, Amant F, Pijnenborg JMA, Kleppe A
doi: 10.1016/j.ejca.2025.116164
CHICAGO 2026
Breast Cancer
NATALEE: Gene expression analysis supports ribociclib plus NSAI across PAM50 intrinsic subtypes in HR-positive, HER2-negative early breast cancer
Gynecologic Cancer
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
★ 3
Recommended and commented by
Dr Andreas Müller, Faculty Member
★ 1
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
Lancet Oncol
Post CCB, de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Leary A, Ottevanger PB, McCormack M, Khaw P, D'Amico R, Fyles A, Chargari C, Kitchener HC, Do V, Lissoni A, Provencher D, Genestie C, Nijman HW, Whitmarsh K, Jürgenliemk-Schulz IM, Feeney A, Lutgens LCHW, Bouma J, Leon-Castillo A, Nout RA, Putter H, Bosse T, Creutzberg CL
doi: 10.1016/S1470-2045(25)00379-1
ESMO 2025
Breast Cancer
LBA1: DESTINY-Breast05: T-DXd significantly improves IDFS and DFS versus T-DM1 in HER2-positive early breast cancer with residual invasive disease
Gynecologic Cancer
Survival Association of Intrauterine Manipulator Use During Minimally Invasive Hysterectomy for Endometrial Cancer: A Systematic Review and Meta-analysis
Obstet Gynecol
Nagase Y, Matsuzaki S, Yoshida H, Nagase S, Tanaka Y, Yamaguchi A, Hisa T, Yokoi T, Ueda Y, Kodama M, Mandai M, Klar M, Roman LD, Ramirez PT, Wright JD, Matsuo K
doi: 10.1097/AOG.0000000000006195
Lung, Respiratory and Thoracic Cancer
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database
J Thorac Oncol
Carbone DP, Hirsch FR, Osarogiagbon RU, Nishimura KK, Tsao MS, Travis WD, Yang D, Yang SR, Yatabe Y, Araujo LH, Detterbeck F, Lechtenberg KJ, Lim E, Mack PC, Matilla JM, Montuenga LM, Nicholson AG, Suda K, Terra RM, Rami-Porta R, Asamura H, Rusch V, Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, and Participating Institutions
doi: 10.1016/j.jtho.2025.06.025
Breast Cancer
Comparison of the pathological complete response between immunohistochemistry HER2 (3 + ) and HER2 (2 + )/ISH + Early-stage breast cancer: a systematic review and meta-analysis
Cancer Treat Rev
Yucel KB, Ilhan Y, Almuradova E, Bardakci M, Dinckal C, Ergun Y
doi: 10.1016/j.ctrv.2025.103074
Head and Neck Cancer
Survival After Fertility-Preserving Hormonal Therapy vs Hysterectomy for Early-Stage Endometrial Cancer
JAMA Oncol
Suzuki Y, Huang Y, Xu X, Ferris JS, Elkin EB, Kong CY, Myers ER, Saji H, Miyagi E, Havrilesky LJ, Blank SV, Hershman DL, Wright JD
doi: 10.1001/jamaoncol.2025.2761
Breast Cancer
Prognostic significance and predictive value of circulating tumor cells in invasive lobular breast carcinoma - an exploratory analysis of the STIC CTC trial
Clin Cancer Res
Sandoval JL, Kiavue N, Djerroudi L, Jacot W, Bachelot T, Bourgeois H, Goncalves A, Brain E, Pierga JY, Alix-Panabieres C, Berger F, Dureau S, Bidard FC
doi: 10.1158/1078-0432.CCR-25-0807